XOMA Royalty (XOMA) Net Margin Growth (3y) (2014 - 2026)
XOMA Royalty (XOMA) Net Margin Growth (3y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
49,253.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
506.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
XOMA Royalty |
5.52 Mn |
-60.56 Mn |
- |
236,348.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
236,348.00 |
| Dec 31, 2025 |
35,746.00 |
| Sep 30, 2025 |
721,429.00 |
| Jun 30, 2025 |
51,215.00 |
| Mar 31, 2025 |
12,564.00 |
| Dec 31, 2024 |
-1.30 Mn |
| Sep 30, 2024 |
-6.85 Mn |
| Jun 30, 2024 |
-2,000.00 |
| Mar 31, 2024 |
125,774.00 |
| Dec 31, 2023 |
-116,969.00 |
| Sep 30, 2023 |
-50,854.00 |
| Jun 30, 2023 |
-6,427.00 |
| Mar 31, 2023 |
-137,563.00 |
| Dec 31, 2022 |
60,603.00 |
| Sep 30, 2022 |
-100,529.00 |
| Jun 30, 2022 |
-6,166.00 |
| Mar 31, 2022 |
-19,578.00 |
| Dec 31, 2021 |
1.51 Mn |
| Sep 30, 2021 |
3,902.00 |
| Jun 30, 2021 |
-16,194.00 |
